Back to top

medical: Archive

Zacks Equity Research

Community Health Systems Stock Falls 7% Amid Debt & Other Pressures

Shares of CYH decline 7%. Heavy debt, soft patient volumes and ongoing investor concerns keep pressure on the hospital operator.

LHNegative Net Change UHSNegative Net Change CYHPositive Net Change

Debanjana Dey

Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell?

HIMS expands into Canada and Europe while facing regulatory hurdles and execution risks in weight-loss care.

TDOCPositive Net Change GDRXNegative Net Change HIMSPositive Net Change

Urmimala Biswas

Is Tempus AI Stock a Buy Now or a Hold After a Big 2025 Run?

Tempus AI rallies in 2025, but a Hold rank and mixed style scores argue for patience until pricing, FDA, and MRD milestones firm up.

IQVNegative Net Change GHNegative Net Change TEMNegative Net Change

Zacks Equity Research

GPCR Stock Soars 102% on Strong Phase II Obesity Data for Aleniglipron

Structure Therapeutics jumps after phase II data show aleniglipron delivering strong, durable weight-loss results across multiple studies.

NVONegative Net Change LLYNegative Net Change VKTXNegative Net Change GPCRNegative Net Change

Zacks Equity Research

Is the Options Market Predicting a Spike in Avantor Stock?

Investors need to pay close attention to AVTR stock based on the movements in the options market lately.

AVTRPositive Net Change

Zacks Equity Research

Is the Options Market Predicting a Spike in Aveanna Healthcare Stock?

Investors need to pay close attention to AVAH stock based on the movements in the options market lately.

AVAHNegative Net Change

Shreya Majumder

Can Flex's Cash Flow & Market Strength Offset Ongoing Macro Pressures?

Flex enters the second half of fiscal 2026 with rising AI demand, strong cash flow and expanding data center momentum despite competitive and macro pressures.

JBLPositive Net Change FLEXPositive Net Change SANMPositive Net Change

Zacks Equity Research

ALGN Stock Rises on Thailand Launch of Invisalign With MAOB

Align Technology's Thailand debut of Invisalign with MAOB lifts shares and expands its Class II treatment options for increasing patients.

ALGNPositive Net Change OMCLPositive Net Change ILMNPositive Net Change BTSGPositive Net Change

Zacks Equity Research

CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery

Carlsmed launches personalized aprevo cervical platform with early cases and new reimbursement support driving momentum in spine surgery.

ISRGNegative Net Change MEDPNegative Net Change CARLPositive Net Change

Zacks Equity Research

Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now

OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk.

BSXNegative Net Change ISRGNegative Net Change OPKPositive Net Change MEDPNegative Net Change

Zacks Equity Research

Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now

TNDM's global expansion and strategic integrations fuel growth potential, even as pump reliance and macro pressures weigh on performance.

OMCLPositive Net Change ILMNPositive Net Change TNDMPositive Net Change BTSGPositive Net Change

Zacks Equity Research

RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort

Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.

OMCLPositive Net Change ILMNPositive Net Change RMDNegative Net Change BTSGPositive Net Change

Zacks Equity Research

Best Growth Stocks to Buy for December 9th

SANM, ALL and PAHC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 9, 2025

ALLPositive Net Change SANMPositive Net Change PAHCNegative Net Change

Zacks Equity Research

New Strong Sell Stocks for December 9th

BRBR, AZTA and BRDCY have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2025.

BRDCYPositive Net Change BRBRPositive Net Change AZTAPositive Net Change

Ekta Bagri

Will Cobenfy Become a Growth Driver for BMY's Neuroscience Business?

Bristol Myers Squibb moves forward with its ADEPT-2 study on Cobenfy, delaying data to next year but boosting investor sentiment.

BIIBNegative Net Change BMYNegative Net Change LLYNegative Net Change

Zacks Equity Research

Can UNH's AI-Powered Virtual Assistance Enhance Member Experience?

UnitedHealth's AI-powered virtual assistants aim to simplify claims, boost engagement and deliver faster, more intuitive healthcare support.

UNHNegative Net Change HUMNegative Net Change ELVNegative Net Change

Zacks Equity Research

PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know

Praxis stock soars after late-stage data show strong efficacy for ulixacaltamide therapy in essential tremor and momentum builds toward an early-2026 regulatory filing.

ANIPPositive Net Change CRMDPositive Net Change ARQTNegative Net Change PRAXNegative Net Change

Zacks Equity Research

Incyte's Rare Blood Cancer Therapy Gets FDA's Breakthrough Status

INCY secures FDA Breakthrough Therapy status for INCA033989 after early data show rapid and sustained platelet normalization in essential thrombocythemia patients.

INCYNegative Net Change ANIPPositive Net Change CRMDPositive Net Change ARQTNegative Net Change

Zacks Equity Research

CONMED Stock Falls as It Strategically Exits Gastroenterology Portfolio

CNMD is set to exit its gastroenterology portfolio to streamline its focus on higher-growth surgical platforms and boost long-term margins.

BSXNegative Net Change CNMDNegative Net Change ISRGNegative Net Change MEDPNegative Net Change

Urmimala Biswas

Tempus AI: Data Flywheel and MRD Expansion Reshape the Outlook

Tempus AI's data engine, MRD buildout and ADLT milestones set the stage for faster growth while profitability metrics turn the corner.

ILMNPositive Net Change GHNegative Net Change TEMNegative Net Change

Swayta Shah

Bet on These 3 Stocks With Upgraded Broker Ratings Amid Uncertainties

Illumina, Commercial Metals and Newmont have all seen broker upgrades, signaling bullish momentum amid market uncertainties.

ILMNPositive Net Change NEMPositive Net Change CMCNegative Net Change

Moumi Mondal

HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?

Hologic shares rise 16% in six months, with divisional strength clinical data and a go-private deal shaping the short-term outlook.

ABTNegative Net Change HOLXPositive Net Change QGENNegative Net Change

Sundeep Ganoria

3 Generic Drug Stocks to Watch Amid Changing U.S. Landscape

Generic drugmakers face U.S. pricing pressure, but TEVA, SDZNY and RDY gain momentum through complex generics and biosimilars.

RDYNegative Net Change TEVAPositive Net Change SDZNYNegative Net Change

Abhinab Dasgupta

Beat the Market the Zacks Way: Veracyte, Las Vegas Sands, 3M in Focus

Veracyte, Las Vegas Sands and 3M shine as Zacks spotlights standout stock gains and portfolio wins amid shifting market sentiment.

KONegative Net Change AMGNNegative Net Change MMMPositive Net Change MUPositive Net Change TMONegative Net Change LRCXPositive Net Change LVSNegative Net Change AUPositive Net Change FOLDPositive Net Change MTZPositive Net Change VCYTNegative Net Change

Indrajit Bandyopadhyay

ISRG Stock Forms Golden Crossover: Will the Uptrend Continue?

Intuitive Surgical's golden crossover arrives amid surging procedures and rapid dV5 adoption, raising the stakes for its bullish momentum.

MDTNegative Net Change SYKNegative Net Change ISRGNegative Net Change